Selective Serotonin Reuptake Inhibitor
Showing 26 - 50 of >10,000
Depression, Serotonin Deficiency Trial in Kelowna (Pharmacological agent: Citalopram, Placebo)
Not yet recruiting
- Depression
- Serotonin Deficiency
- Pharmacological agent: Citalopram
- Placebo
-
Kelowna, British Columbia, CanadaUniversity of British Columbia, Okanagan Campus
Jul 19, 2023
Neurodevelopmental Disorders, Autism, Autism Spectrum Disorder Trial in Canada (Sertraline, Placebo)
Not yet recruiting
- Neurodevelopmental Disorders
- +25 more
- Sertraline
- Placebo
-
Calgary, Alberta, Canada
- +6 more
Oct 11, 2023
Chest Pain Rule Out Myocardial Infarction Trial in Athens (Citalopram)
Terminated
- Chest Pain Rule Out Myocardial Infarction
-
Athens, Attiki, GreeceEvangelismos Hospital
Nov 27, 2019
Meniere Disease Trial in Charleston (Venlafaxine, Placebo oral tablet)
Recruiting
- Meniere Disease
- Venlafaxine
- Placebo oral tablet
-
Charleston, South CarolinaMedical Univeristy of South Carolina
Dec 2, 2021
DaTSCAN Brain Scintigraphy and Psychotropic Treatments:
Not yet recruiting
- Parkinson Disease
- scintigraphy DaTSCAN
-
Vandœuvre-lès-Nancy, FranceCHRU Nancy
Jan 5, 2023
Depression, Parkinson Disease Trial (Nortriptyline, Escitalopram, Placebo)
Recruiting
- Depression
- Parkinson Disease
- Nortriptyline
- +2 more
-
London, United KingdomRoyal Free London NHS Foundation Trust
Nov 2, 2022
OCD Trial in Dhaka (N-acetylcysteine tablet 600mg, Placebo tablet 600mg)
Recruiting
- OCD
- N-acetylcysteine tablet 600mg
- Placebo tablet 600mg
-
Dhaka, Bangladesh
- +1 more
Nov 14, 2021
Obesity, Depression Trial in Lucerne (Roux-en-Y gastric bypass, sleeve gastrectomy)
Completed
- Obesity
- Depression
- Roux-en-Y gastric bypass, sleeve gastrectomy
-
Lucerne, SwitzerlandLuzerner Kantonsspital
Jun 9, 2021
Depressive Disorder, Major Trial in Worldwide (Esketamine, SSRI/SNRI)
Active, not recruiting
- Depressive Disorder, Major
-
Ciudad Autonoma de Buenos Aires, Argentina
- +58 more
Jan 31, 2023
None (i.e. Healthy Volunteers) Trial in Ottawa (Levomilnacipran, Duloxetine, Placebos)
Active, not recruiting
- None (i.e. Healthy Volunteers)
- Levomilnacipran
- +2 more
-
Ottawa, Ontario, CanadaInstitute of Mental Health Research, Royal Ottawa Mental Health
Oct 5, 2021
Generalized Anxiety Disorder Trial in Kingston (SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and
Completed
- Generalized Anxiety Disorder
- SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors)
- Electronic Cognitive Behavioural Therapy
-
Kingston, Ontario, CanadaHotel Dieu Hospital
Sep 7, 2021
Healthy Trial in Shanghai (HEC113995PA•H2O tablet, Placebo tablet)
Completed
- Healthy
- HEC113995PA•H2O tablet
- Placebo tablet
-
Shanghai, Shanghai, ChinaThe Shanghai xuhui district central hospital
May 11, 2021
MDD Trial in Bhubaneswar (Selective Serotonin Reuptake Inhibitors, Dextromethorphan, Placebo)
Recruiting
- Major Depressive Disorder
- Selective Serotonin Reuptake Inhibitors
- +2 more
-
Bhubaneswar, Odisha, IndiaAll India Institute of Medical Sciences (AIIMS)
Feb 11, 2022
MDD Trial in Hangzhou (SSRI, SIA, AIA)
Recruiting
- Major Depressive Disorder
- SSRI
- +2 more
-
Hangzhou, Zhejiang, Chinathe Third affiliated hospital of Zhejiang Chinese Medical univer
Jan 31, 2023
Antidepressants in Advance of Investigational Trials
Recruiting
- Major Depressive Disorder
- FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)
-
Watertown, MassachusettsAdams Clinical
Mar 9, 2021
Depression, MDD, Mild Depression Trial in Abbotsford (Psilocybin)
Not yet recruiting
- Depression
- +4 more
-
Abbotsford, British Columbia, CanadaCentre for Neurology Studies x Upstream
Oct 25, 2022
Anxiety Disorder, Insomnia Trial in Changxing, Linping, Yiwu (Pulse magnetic therapy, Selective serotonin reuptake inhibitors
Recruiting
- Anxiety Disorder
- Insomnia
- Pulse magnetic therapy
- +2 more
-
Changxing, Zhejiang, China
- +2 more
Jan 30, 2023
MDD, Recurrent, Unspecified, MDD, Single Episode, Unspecified Trial in Worldwide (H-Coil Deep TMS in combination with SSRIs)
Completed
- Major Depressive Disorder, Recurrent, Unspecified
- Major Depressive Disorder, Single Episode, Unspecified
- H-Coil Deep TMS in combination with SSRIs
-
Davis, California
- +18 more
Jul 13, 2020
Depressive Disorder, Major, Anhedonia Trial in Worldwide (Aticaprant, Placebo)
Recruiting
- Depressive Disorder, Major
- Anhedonia
- Aticaprant
- Placebo
-
Birmingham, Alabama
- +156 more
Jan 31, 2023
Tibial Plateau Fracture, Pain, Postoperative Trial in Boston, Valhalla (Duloxetine, Placebo, Standard of care (SOC) for tibial
Not yet recruiting
- Tibial Plateau Fracture
- Pain, Postoperative
- Duloxetine
- +2 more
-
Boston, Massachusetts
- +1 more
Aug 6, 2022
Depressive Disorder, Major, Anhedonia Trial in Worldwide (Aticrapant, Placebo)
Recruiting
- Depressive Disorder, Major
- Anhedonia
- Aticrapant
- Placebo
-
Phoenix, Arizona
- +72 more
Jul 10, 2022
Depression, MDD, Dysthymic Disorder Trial in Indianapolis (behavioral, drug, other)
Recruiting
- Depression
- +6 more
- Good Days Ahead (GDA)
- +3 more
-
Indianapolis, IndianaIUPUI Department of Psychology
Jan 18, 2022
Antidepressants in Advance of Investigational Trials, Relapse
Recruiting
- Major Depressive Disorder
- FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)
-
Watertown, MassachusettsAdams Clinical
Jun 14, 2021